BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28806388)

  • 1. Naltrexone- or Nalmefene-Related Buprenorphine Withdrawal: Treat It With… More Buprenorphine.
    Lescut C; Gaboriau L; Carton L; Rolland B
    J Clin Psychopharmacol; 2017 Oct; 37(5):631-633. PubMed ID: 28806388
    [No Abstract]   [Full Text] [Related]  

  • 2. Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting.
    Pélissier F; Rougé Bugat ME; Nubukpo P; Franchitto N
    J Clin Psychopharmacol; 2016 Feb; 36(1):100-3. PubMed ID: 26658085
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid heroin detoxification using a single high dose of buprenorphine.
    Kutz I; Reznik V
    J Psychoactive Drugs; 2001; 33(2):191-3. PubMed ID: 11476266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe opioid withdrawal syndrome after a single dose of nalmefene.
    Donnerstag N; Schneider T; Lüthi A; Taegtmeyer A; Raetz Bravo A; Mehlig A
    Eur J Clin Pharmacol; 2015 Aug; 71(8):1025-6. PubMed ID: 26050241
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose.
    Clark NC; Lintzeris N; Muhleisen PJ
    Med J Aust; 2002 Feb; 176(4):166-7. PubMed ID: 11913917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone.
    Fishman M
    Addiction; 2008 Aug; 103(8):1399-401. PubMed ID: 18855831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elective Naloxone-Induced Opioid Withdrawal for Rapid Initiation of Medication-Assisted Treatment of Opioid Use Disorder.
    Phillips RH; Salzman M; Haroz R; Rafeq R; Mazzarelli AJ; Pelletier-Bui A
    Ann Emerg Med; 2019 Sep; 74(3):430-432. PubMed ID: 30773411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, double-dummy, randomized controlled study of memantine versus buprenorphine in naloxone-precipitated acute withdrawal in heroin addicts.
    Jain K; Jain R; Dhawan A
    J Opioid Manag; 2011; 7(1):11-20. PubMed ID: 21434580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.
    Franchitto N; Jullian B; Salles J; Pelissier F; Rolland B
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):669-677. PubMed ID: 28343423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial.
    Schottenfeld RS; Chawarski MC; Mazlan M
    Lancet; 2008 Jun; 371(9631):2192-200. PubMed ID: 18586174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine.
    Yéléhé-Okouma M; Martini H; Lemarié J; Labroca P; Petitpain N; Gibaja V; Paille F; Gillet P
    Fundam Clin Pharmacol; 2017 Oct; 31(5):574-579. PubMed ID: 28322465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unplanned admissions to two Sydney public hospitals after naltrexone implants.
    Little M; Murray LM
    Med J Aust; 2008 Oct; 189(8):469; author reply 470-1. PubMed ID: 19024885
    [No Abstract]   [Full Text] [Related]  

  • 14. Heroin detoxification.
    Favrat B; Besson J
    JAMA; 2006 Feb; 295(8):885; author reply 886. PubMed ID: 16493096
    [No Abstract]   [Full Text] [Related]  

  • 15. Heroin detoxification.
    Miller MM
    JAMA; 2006 Feb; 295(8):885-6; author reply 886. PubMed ID: 16493095
    [No Abstract]   [Full Text] [Related]  

  • 16. Retrospective analysis of heroin detoxification with buprenorphine in a psychiatric hospital in Japan.
    Nagano T; Kimoto S; Aso K; Komori T; Yamaguchi Y; Okamura K; Yamamoto N; Kishimoto T
    Neuropsychopharmacol Rep; 2020 Dec; 40(4):376-382. PubMed ID: 33107693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
    Blennow G; Fergusson A; Medvedeo A
    Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unplanned admissions to two Sydney public hospitals after naltrexone implants.
    Lloyd-Jones DM
    Med J Aust; 2008 Oct; 189(8):468-9; author reply 470-1. PubMed ID: 18928445
    [No Abstract]   [Full Text] [Related]  

  • 19. Unplanned admissions to two Sydney public hospitals after naltrexone implants.
    Kozminsky MP
    Med J Aust; 2008 Oct; 189(8):469-70; author reply 470-1. PubMed ID: 19031547
    [No Abstract]   [Full Text] [Related]  

  • 20. Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report.
    Szczesniak LM; Calleo VJ; Sullivan RW
    Harm Reduct J; 2020 Oct; 17(1):71. PubMed ID: 33028340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.